FDA-Approved Drugs

FDA-Approved Drugs

The following drugs have been approved since the year 2000 for the treatment of non-Hodgkin's lymphoma:

Treanda (bendamustine)

FDA approved October 2008

Bendamustine is a chemotherapy drug approved for the treatment of B-cell non-Hodgkin lymphomas.

Arranon (nelarabine)

FDA approved October 2005

This chemotherapy drug is approved for the treatment of T-cell lymphoblastic lymphoma.

Bexxar (tositumomab)

FDA approved June 2003

This drug is a monoclonal antibody that targets specific lymphoma cells. Tositumomab is linked to a radioactive agent called iodine-131 (I-131). The medicine allows radiation to be delivered directly to the sites of the lymphoma.

Zevalin (ibritumomab tiuxetan)

FDA approved February 2002

This drug is a protein that targets specific lymphoma cells. To be effective ibritumomab tiuxetan is linked to a radioactive agent called yttrium chloride (Y-90). The medicine allows radiation to be delivered directly to the sites of the lymphoma.

 
Today's Interactive Tools
Related Items

Bayhealth is Southern Delaware’s healthcare leader with hospitals in Dover and in Milford. Bayhealth provides a wide range of medical services, including cardiovascular, oncology, orthopedics and rehabilitation, pediatrics, respiratory care, sleep care, surgical weight loss, women’s services and walk-in medical care. Search for nursing jobs, and health classes and events. Find doctors affiliated with Bayhealth Medical Center or a Delaware hospital near you.